Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

DNA Damage Repair Pathway Alterations and Immune Landscape Differences in Pediatric/Adolescent, Young Adult (AYA) and Adult Sarcomas

Cancers(2025)10.3390/cancers17121962Source: DataRank Database

DNA Damage Repair Pathway Alterations and Immune Landscape Differences in Pediatric/Adolescent, Young Adult (AYA) and Adult Sarcomas is a research paper published in Cancers (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.13)OA: goldTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Andrew Elliott ORCID,Steven Bialick ORCID,César Serrano ORCID,Margaret von Mehren ORCID,Matthew J. Oberley ORCID

Live enrichment

PubMed:40563612 PMC:PMC12191036 OpenAlex:https://openalex.org/W4411235093

National Cancer Institute of the National Institutes of Health

Grant: P30CA240139

National Cancer Institute of the National Institutes of Health

Grant: R01CA253986

CRIS

Grant: CRIS-excellence2023_44

NIH HHS

Grant: 1P30CA240139-20S6

NIH HHS

Grant: 1R01CA253986-24S3

Carlos III Institute of Health

Grant: ISCIII PI22-00720

National Institutes of Health

Grant: 7R01CA253986-02

SIRT5 inhibitors and degraders as novel treatments for Ewing sarcoma

National Institutes of Health

Grant: 3P30CA240139-02S3

The Sylvester Cancer Center Support Grant

FWCI

1.13

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2072-6694/17/12/1962/pdf?version=1749732655

publisherhttps://www.mdpi.com/2072-6694/17/12/1962/pdf?version=1749732655

publisherhttps://www.mdpi.com/2072-6694/17/12/1962/pdf

journalhttps://doi.org/10.3390/cancers17121962

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40563612

Fields of Study

DNA Repair MechanismsPARP inhibition in cancer therapySarcoma Diagnosis and Treatment03 medical and health sciences0302 clinical medicine

Keywords

Immune systemDNA damageYoung adultMedicineDNA repairImmunologyDNACancer researchBiologyGeneticsInternal medicineSarcomaDna Damage ResponsePrecision MedicineFENÓMENOS Y PROCESOS::fenómenos genéticos::variación genética::mutaciónOther subheadings::Other subheadings::Other subheadings::/geneticsFENÓMENOS Y PROCESOS::fenómenos genéticos::daño del ADNADN - DanyCàncer - Aspectes genèticsArticleDISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::SarcomaENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::sarcomaPHENOMENA AND PROCESSES::Genetic Phenomena::DNA DamageDISEASES::NeoplasmsAnomalies cromosòmiquesENFERMEDADES::neoplasiasPHENOMENA AND PROCESSES::Genetic Phenomena::Genetic Variation::MutationOtros calificadores::Otros calificadores::Otros calificadores::/genéticaSarcoma - Aspectes genètics